190 related articles for article (PubMed ID: 37130727)
1. Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies.
Pinal-Fernandez I; Milisenda JC; Pak K; Muñoz-Braceras S; Casal-Dominguez M; Torres-Ruiz J; Dell'Orso S; Naz F; Gutierrez-Cruz G; Duque-Jaimez Y; Matas-Garcia A; Padrosa J; Garcia-Garcia FJ; Guitart-Mampel M; Garrabou G; Trallero-Araguás E; Walitt B; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Grau-Junyent JM; Selva-O'Callaghan A; Mammen AL
Ann Rheum Dis; 2023 Aug; 82(8):1091-1097. PubMed ID: 37130727
[TBL] [Abstract][Full Text] [Related]
2. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis.
Pinal-Fernandez I; Casal-Dominguez M; Derfoul A; Pak K; Miller FW; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Carrion-Ribas C; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
Ann Rheum Dis; 2020 Sep; 79(9):1234-1242. PubMed ID: 32546599
[TBL] [Abstract][Full Text] [Related]
3. More prominent muscle involvement in patients with dermatomyositis with anti-Mi2 autoantibodies.
Pinal-Fernandez I; Mecoli CA; Casal-Dominguez M; Pak K; Hosono Y; Huapaya J; Huang W; Albayda J; Tiniakou E; Paik JJ; Johnson C; Danoff SK; Corse AM; Christopher-Stine L; Mammen AL
Neurology; 2019 Nov; 93(19):e1768-e1777. PubMed ID: 31594859
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis.
Pinal-Fernandez I; Quintana A; Milisenda JC; Casal-Dominguez M; Muñoz-Braceras S; Derfoul A; Torres-Ruiz J; Pak K; Dell'Orso S; Naz F; Gutierrez-Cruz G; Milone M; Shelly S; Duque-Jaimez Y; Tobias-Baraja E; Matas-Garcia A; Garrabou G; Padrosa J; Ros J; Trallero-Araguás E; Walitt B; Christopher-Stine L; Lloyd TE; Zhao C; Swift S; Rajan A; Grau-Junyent JM; Selva-O'Callaghan A; Liewluck T; Mammen AL
Ann Rheum Dis; 2023 Jun; 82(6):829-836. PubMed ID: 36801811
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic autoantibody internalization in myositis.
Pinal-Fernandez I; Muñoz-Braceras S; Casal-Dominguez M; Pak K; Torres-Ruiz J; Musai J; Dell'Orso S; Naz F; Islam S; Gutierrez-Cruz G; Cano MD; Matas-Garcia A; Padrosa J; Tobías-Baraja E; Garrabou G; Aldecoa I; Espinosa G; Simeon-Aznar CP; Guillen-Del-Castillo A; Gil-Vila A; Trallero-Araguas E; Christopher-Stine L; Lloyd TE; Liewluck T; Naddaf E; Stenzel W; Greenberg SA; Grau JM; Selva-O'Callaghan A; Milisenda JC; Mammen AL
medRxiv; 2024 Jan; ():. PubMed ID: 38313303
[TBL] [Abstract][Full Text] [Related]
6. Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis.
Fornaro M; Girolamo F; Cavagna L; Franceschini F; Giannini M; Amati A; Lia A; Tampoia M; D'Abbicco D; Maggi L; Fredi M; Zanframundo G; Moschetti L; Coladonato L; Iannone F
Rheumatology (Oxford); 2021 Jun; 60(6):2916-2926. PubMed ID: 33249503
[TBL] [Abstract][Full Text] [Related]
7. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.
Pinal-Fernandez I; Casal-Dominguez M; Carrino JA; Lahouti AH; Basharat P; Albayda J; Paik JJ; Ahlawat S; Danoff SK; Lloyd TE; Mammen AL; Christopher-Stine L
Ann Rheum Dis; 2017 Apr; 76(4):681-687. PubMed ID: 27651398
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies in polymyositis and dermatomyositis.
Ghirardello A; Bassi N; Palma L; Borella E; Domeneghetti M; Punzi L; Doria A
Curr Rheumatol Rep; 2013 Jun; 15(6):335. PubMed ID: 23591825
[TBL] [Abstract][Full Text] [Related]
9. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
[TBL] [Abstract][Full Text] [Related]
10. Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies.
Casal-Dominguez M; Pinal-Fernandez I; Corse AM; Paik J; Albayda J; Casciola-Rosen L; Johnson C; Danoff SK; Christopher-Stine L; Tiniakou E; Mammen AL
Neurology; 2019 Mar; 92(13):e1416-e1426. PubMed ID: 30824556
[TBL] [Abstract][Full Text] [Related]
11. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
[TBL] [Abstract][Full Text] [Related]
12. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A
Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory muscle disease - An update.
Baig S; Paik JJ
Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101484. PubMed ID: 32046904
[TBL] [Abstract][Full Text] [Related]
14. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
15. Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort.
Fornaro M; Coladonato L; Giannini M; Napoletano A; Girolamo F; D'Abbicco D; Ruggieri M; Sabella DVA; Iannone F
Clin Exp Rheumatol; 2024 Feb; 42(2):295-301. PubMed ID: 38488098
[TBL] [Abstract][Full Text] [Related]
16. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic myopathies.
Mammen AL
Handb Clin Neurol; 2024; 200():327-332. PubMed ID: 38494286
[TBL] [Abstract][Full Text] [Related]
18. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
Srivastava P; Dwivedi S; Misra R
Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
[TBL] [Abstract][Full Text] [Related]
19. [Autoantibody profile in myositis].
Allenbach Y; Benveniste O
Rev Med Interne; 2014 Jul; 35(7):437-43. PubMed ID: 24387952
[TBL] [Abstract][Full Text] [Related]
20. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
